Relacatib

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NameRelacatib

Drug Alias NameGSK-462795SB-462795

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionCathepsin K inhibitors

TargetsCathepsin K

Therapy Area/IndicationsOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A

Related LinksN/A